Think of it as a two-part journey: a powerful initial push, followed by a steady, long-term cruise
View Study [2]"Safety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide with semaglutide" Enebo LB et al., 2021 Finding: Phase 1b trial demonstrated that combining cagrilintide with semaglutide 2.4mg resulted in up to 17.1% weight loss at 20 weeks, with the combination being well-tolerated
The abdomen (avoiding a 2-inch radius around the navel), outer thigh, and upper arm provide suitable injection locations with adequate subcutaneous tissue
The mice were injected intravenously with PBS, Ru(II)-OH, NP2, NP4 (2 mg/kg Ru) on days 1, 4, 7, 10, respectively
Contact Estheticare Clinic today to schedule a personalized consultation with our experienced medical team